BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

544529

APPL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Aptus Pharma Ltd Share Price Update

As of the latest trading session, Aptus Pharma Ltd share price is currently at ₹ 152, which is down by ₹ -7.94 from its previous closing. Today, the stock has fluctuated between ₹ 152.00 and ₹ 156.85. Over the past year, Aptus Pharma Ltd has achieved a return of [-] %. In the last month alone, the return has been 63.88 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Aptus Pharma Ltd fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    104.30

  • P/E Ratio (TTM)

    0.00

  • Beta

    4.92

  • Book Value / share

    29.13

  • Return on equity

    70.94%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Aptus Pharma Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 24.56
Operating Expense 20.54
Net Profit 2.96
Net Profit Margin (%) 12.05
Earnings Per Share (EPS) 6.08
EBITDA 4.82
Effective Tax Rate (%) 27.80
Particulars MAR 2024 (Values in Cr)
Revenue 17.86
Operating Expense 16.77
Net Profit 0.80
Net Profit Margin (%) 4.47
Earnings Per Share (EPS) 26.60
EBITDA 1.57
Effective Tax Rate (%) 28.57
Particulars MAR 2023 (Values in Cr)
Revenue 13.90
Operating Expense 13.60
Net Profit 0.19
Net Profit Margin (%) 1.36
Earnings Per Share (EPS) 6.48
EBITDA 0.62
Effective Tax Rate (%) 33.33
Particulars MAR 2025 (Values in Cr)
Book Value / Share 13.93
ROE % 70.94
ROCE % 37.63
Total Debt to Total Equity 1.79
EBITDA Margin 20.07
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.88
ROE % 58.39
ROCE % 25.83
Total Debt to Total Equity 2.74
EBITDA Margin 8.79
Particulars MAR 2023 (Values in Cr)
Book Value / Share 32.28
ROE % 19.59
ROCE % 13.07
Total Debt to Total Equity 2.28
EBITDA Margin 4.46
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 5.21
Total Assets 21.91
Total Liabilities 21.91
Total Equity 6.96
Share Outstanding 5000000
Price to Book Ratio 0.00
Return on Assets (%) 14.14
Return on Capital (%) 17.89
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 10.02
Total Liabilities 10.02
Total Equity 1.76
Share Outstanding 300000
Price to Book Ratio 0.00
Return on Assets (%) 7.95
Return on Capital (%) 11.28
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.53
Total Assets 6.21
Total Liabilities 6.21
Total Equity 0.96
Share Outstanding 300000
Price to Book Ratio 0.00
Return on Assets (%) 3.12
Return on Capital (%) 6.11
Particulars MAR 2025 (Values in Cr)
Net Income 4.19
Cash from Operations -0.72
Cash from Investing -0.54
Cash from Financing 6.68
Net change in Cash 4.29
Free Cash Flow -0.10
Particulars MAR 2024 (Values in Cr)
Net Income 1.11
Cash from Operations -1.83
Cash from Investing -0.30
Cash from Financing 2.85
Net change in Cash 0.37
Free Cash Flow -1.50
Particulars MAR 2023 (Values in Cr)
Net Income 0.29
Cash from Operations -0.06
Cash from Investing -0.35
Cash from Financing 0.81
Net change in Cash 0.27
Free Cash Flow 0.29
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 30.76 15.08 1.59 235.72 30.00 / 68.00
BLISS GVS PHARMA LTD 161.90 15.61 1.62 1711.65 105.05 / 190.65
CIPLA LTD 1531.65 22.74 3.75 123722.28 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 291.85 7.67 2.19 858.94 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2477.90 44.04 24.58 41977.12 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 30.76 25.01 4.28 235.72 30.00 / 68.00
AMRUTAJAN HEALTH LTD 719.05 36.67 6.07 2078.82 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9155.10 99.01 28.64 22887.75 6222.35 / 10653.05
BLISS GVS PHARMA LTD 161.90 21.85 1.61 1711.65 105.05 / 190.65

Aptus Pharma Ltd shareholding pattern

Holding

Others
14.28%
Promoter Holdings
72.88%
FII
10.02%
DII
2.79%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Kapilbhai Hasmukhbhai Chandarana 775000.0 (11.3%) Shareholding of Promoter and Promoter Group
Tejash Maheshchandra Hathi 775000.0 (11.3%) Shareholding of Promoter and Promoter Group
Gaurang Rameshchandra Thakker 575000.0 (8.38%) Shareholding of Promoter and Promoter Group
Kunjal Piyushbhai Unadkat 575000.0 (8.38%) Shareholding of Promoter and Promoter Group
Milly Chetan Lalseta 575000.0 (8.38%) Shareholding of Promoter and Promoter Group
Kripaliben Mayank Thakker 575000.0 (8.38%) Shareholding of Promoter and Promoter Group
Riddhish Natwarlal Tanna 575000.0 (8.38%) Shareholding of Promoter and Promoter Group
Ghanshyam Vinubhai Pansuriya 350000.0 (5.1%) Shareholding of Promoter and Promoter Group
Saint Capital Fund 294000.0 (4.29%) Public Shareholding
Chatrabhuj Vallabhbhai Butani 225000.0 (3.28%) Shareholding of Promoter and Promoter Group
Eminence Global Fund Pcc- Eubilia Capital Partners Fund I 192000.0 (2.8%) Public Shareholding
31 Degrees North Fund-31 Degrees North Fund I 192000.0 (2.8%) Public Shareholding
Zeal Global Opportunities Fund 144000.0 (2.1%) Public Shareholding

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Aptus Pharma Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
152.00 -4.97 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 155.20
  • 26 Days 127.50
  • 10 Days 149.20
  • 50 Days 120.30
  • 12 Days 146.50
  • 100 Days 120.30
  • 20 Days 135.00
  • 200 Days 120.30
162.53 PIVOT

First Support

157.37

First Resistance

165.12

Second Support

154.78

Second Resistance

170.28

Third Support

149.62

Third Resistance

172.87

RSI

65.96

ADX

63.10

MACD

18.98

Williams % R

-33.99

Commodity Channel Index (CCI)

99.04

Date

2025-11-14

Week

64667.00

Same Day

34000.00

Month

78818.00

1 Year

4.92

3 Year

4.83

Over 1 Month

63.88%

down

Over 1 Year

0.00%

down

Over 3 Months

79.16%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Aptus Pharma Ltd Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Aptus Pharma Ltd Share Price

Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010. Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre.

Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements. It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.

The Company started business through 4 regional headquarters in Gujarat in 2011. It launched a portfolio of nearly 25 products targeting essential therapeutic divisions in 2013. It expanded the operations to over 50 products, catering to both acute and chronic segments in 2015. This resulted the increase in portfolio to 70 products in 2019 and to over 100 in 2022. The Company enhanced the production to over 175 products in 2024. It established 3 operational divisions: Acute, Chronic, and OTC in 2024.

Company is planning the Initial Public Issue of 20,00,000 equity shares of face value of Rs 10 each through fresh issue.

Parent organization Indian Private
NSE symbol [-]
Founded 2010
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Aptus Pharma Ltd?

Answer Field

Aptus Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 152.00 as on Nov 14 2025 03:26 PM.

What is the Market Cap of Aptus Pharma Ltd Share?

Answer Field

The market cap of Aptus Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 104.30 as on Nov 14 2025 03:26 PM.

What is the 52 Week High and Low of Aptus Pharma Ltd?

Answer Field

The 52 Week High and Low of Aptus Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 168.35 and ₹ 80.80.

What is 1 year return for Aptus Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Aptus Pharma Ltd Share?

Answer Field

As on Nov 14 2025 03:26 PM the price-to-earnings (PE) ratio for Aptus Pharma Ltd share is 0.00.

What is the PB ratio of Aptus Pharma Ltd Share?

Answer Field

As on Nov 14 2025 03:26 PM, the price-to-book (PB) ratio for Aptus Pharma Ltd share is 29.13.

How to Buy Aptus Pharma Ltd Share?

Answer Field

You can trade in Aptus Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aptus Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Aptus Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aptus Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59